Lilly image

Phoenix from the flames for Lilly cancer drug

August 14, 2013
Research and Development, Sales and Marketing NSCLC, lilly, lung cancer, necitumumab

A drug that once looked doomed to fail has shocked analysts by helping late-stage lung cancer patients live longer. Necitumumab …

anne_lindblad_emmes

New president and chief executive for EMMES

August 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMMES

Research support firm The EMMES Corporation has announced that its executive VP Dr Anne Lindblad has been promoted to president …

FDA image

FDA project will examine abuse-resistant formulations

August 13, 2013
Manufacturing and Production API, CDC, FDA

The FDA is seeking tenders for a research project to examine how effective tamper-resistant formulations of opioid analgesics really are …

The new NHS: a marriage of inconvenience?

August 13, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS England, andy lee, market access, quarry house

As NHS England tries to squeeze more money out of the healthcare budget to pay for specialist commissioning, Andy Lee …

Rebrand for Just:: comms agency

August 13, 2013
Medical Communications Just:: Health

London-based healthcare agency Just:: Health PR has changed its name to Just:: Health Communications. The move is in response to …

Vical image

Vical melanoma drug dropped

August 13, 2013
Research and Development, Sales and Marketing Vical, allovectin, melanoma

Vical has abandoned trials of a late-stage drug for the deadliest form of skin cancer after the treatment failed to …

Malaria image

Sanaria’s malaria vaccine shows promise

August 9, 2013
Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria

Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …

NICE image

AllTrials campaign releases manifesto

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency

The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …

Ranbaxy image

Ranbaxy taps into Malaysian growth with second facility

August 9, 2013
Manufacturing and Production ASEAN, Ranbaxy, asian, malaysian

Indian drugmaker Ranbaxy has signed a deal to construct a new $35 million manufacturing facility in Malaysia that will triple …

GSK banks on bioelectronics with new fund

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …

glen_campbell_bmj

BMJ appoints US managing director

August 9, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMJ, Campbell

Medical journal BMJ has hired Glen Campbell from Elsevier to be its US managing director. Campbell joins BMJ on 2 …

Votrient image

GSK seeks licence extensions

August 8, 2013
Sales and Marketing Cervarix, EMA, GSK, Votrient

GlaxoSmithKline is seeking to extend the licences of two of its brands, Cervarix and Votrient, in a bid to extend …

Novartis image

Novartis recognised for efforts in cancer

August 8, 2013
Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis

Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …

Afinitor image

Late-stage failure for Afinitor

August 8, 2013
Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …

The Gateway to Local Adoption Series

Latest content